» Articles » PMID: 11094449

Fibroblast Biology. Role of Synovial Fibroblasts in the Pathogenesis of Rheumatoid Arthritis

Overview
Journal Arthritis Res
Specialty Rheumatology
Date 2000 Nov 30
PMID 11094449
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing evidence that activated synovial fibroblasts, as part of a complex cellular network, play an important role in the pathogenesis of rheumatoid arthritis. In recent years, significant progress has been made in elucidating the specific features of these fibroblasts. It has been understood that although macrophage and lymphocyte secreted factors contribute to their activation, rheumatoid arthritis synovial fibroblasts (RA-SFs) do not merely respond to stimulation by pro-inflammatory cytokines, but show a complex pattern of molecular changes also maintained in the absence of external stimulation. This pattern of activation is characterized by alterations in the expression of regulatory genes and signaling cascades, as well as changes in pathways leading to apoptosis. These together result in the upregulation of adhesion molecules that mediate the attachment of RA-SFs to the extracellular matrix and in the overexpression of matrix degrading enzymes that mediate the progressive destruction of the joints. In addition, activated RA-SFs exert specific effects on other cell types such as macrophages and lymphocytes. While the initiating step in the activation of RA-SFs remains elusive, several key pathways of RA-SF activation have been identified. However, there is so far no single, specific marker for this phenotype of RA-SF. It appears that activated RA-SFs are characterized by a set of specific properties which together lead to their aggressive behavior.

Citing Articles

ER O-glycosylation in synovial fibroblasts drives cartilage degradation.

Tran L, Chia J, Le Guezennec X, Tham K, Nguyen A, Sandrin V Nat Commun. 2025; 16(1):2535.

PMID: 40087276 DOI: 10.1038/s41467-025-57401-9.


Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives.

Miyamoto A, Shimagami H, Kumanogoh A, Nishide M Inflamm Regen. 2025; 45(1):6.

PMID: 39980019 PMC: 11841260. DOI: 10.1186/s41232-025-00369-2.


Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Lee H, Yoo S, Kim J, Lee Y, Joo H, Jeon B Cent Eur J Immunol. 2024; 49(2):113-125.

PMID: 39381557 PMC: 11457561. DOI: 10.5114/ceji.2024.141946.


drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling components.

Roumelioti F, Tzaferis C, Konstantopoulos D, Papadopoulou D, Prados A, Sakkou M Elife. 2024; 13.

PMID: 39235454 PMC: 11377061. DOI: 10.7554/eLife.84698.


Ameliorative effects of undifferentiated and differentiated BM-MSCs in MIA-induced osteoarthritic Wistar rats: roles of NF-κB and MMPs signaling pathways.

Saleh A, Abdel-Gabbar M, Gabr H, Shams A, Tamur S, Mahdi E Am J Transl Res. 2024; 16(7):2793-2813.

PMID: 39114694 PMC: 11301505. DOI: 10.62347/FGHV2647.


References
1.
Alsalameh S, Winter K, Wendler J, Kalden J, Kinne R . Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol. 1999; 49(3):278-85. DOI: 10.1046/j.1365-3083.1999.00458.x. View

2.
Hamann J, Wishaupt J, van Lier R, Smeets T, Breedveld F, Tak P . Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum. 1999; 42(4):650-8. DOI: 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S. View

3.
Lindhout E, van Eijk M, van Pel M, Lindeman J, Dinant H, de Groot C . Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol. 1999; 162(10):5949-56. View

4.
Ogasawara H, Sekigawa I, Hashimoto H, Kaneko Y, Hirose S . Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells. Immunology. 1999; 96(2):215-9. PMC: 2326730. DOI: 10.1046/j.1365-2567.1999.00693.x. View

5.
Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y . C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 1999; 42(5):954-62. DOI: 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J. View